Editing policy to fit the genome?
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Framing genome editing policy requires setting thresholds of acceptability
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 2016, Isasi, Kleiderman, and Knoppers reviewed ''a representative sample of 16 countries to provide a global 'snapshot' of the spectrum of policy and legislative approaches'' to a number of interventions involving modification of the human germline for reproductive purposes.30”
From Human Germline and Heritable Genome Editing: The Global Policy Landscape (2020) · cites this paper as [30]
Citations
Cites
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
A prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 733
Don’t edit the human germ line
Lanphier, E., Urnov, F., Haecker, S. E., Werner, M., & Smolenski, J. (2015) · Nature · doi:10.1038/519410a · Cited by 530
Caplan, A. L., Parent, B., Shen, M., & Plunkett, C. (2015) · EMBO reports · doi:10.15252/embr.201541337 · Cited by 162
Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
LaFountaine, J. S., Fathe, K., & Smyth, H. D. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.029 · Cited by 111
Preimplantation Genetic Diagnosis: An Overview of Socio-Ethical and Legal Considerations
Knoppers, B. M., Bordet, S., & Isasi, R. M. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115753 · Cited by 96
Self-citationMind the Gap: Policy Approaches to Embryonic Stem Cell and Cloning Research in 50 Countries
Isasi, R. M., & Knoppers, B. M. (2006) · European Journal of Health Law · doi:10.1163/157180906777036328 · Cited by 90
Self-citationEthics and germline gene editing
Sugarman, J. (2015) · EMBO Reports · doi:10.15252/embr.201540879 · Cited by 59
Regulatory approaches to reproductive genetic testing
Knoppers, B. M., & Isasi, R. M. (2004) · Human Reproduction · doi:10.1093/humrep/deh505 · Cited by 57
Self-citationIsasi, R. M., & Knoppers, B. M. (2006) · Human Reproduction · doi:10.1093/humrep/del235 · Cited by 51
Self-citation
Cited by
Ovarian ageing: the role of mitochondria in oocytes and follicles
May-Panloup, P., Boucret, L., Chao de la Barca, J.-M., Desquiret-Dumas, V., Ferré-L'Hotellier, V., Morinière, C., Descamps, P., Procaccio, V., & Reynier, P. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw028 · Cited by 577
Ormond, K. E., Mortlock, D. P., Scholes, D. T., Bombard, Y., Brody, L. C., Faucett, W. A., Garrison, N. A., Hercher, L., Isasi, R., Middleton, A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.012 · Cited by 252
Self-citationMitochondrial Dysfunction and Ovarian Aging
Kasapoğlu, I., & Seli, E. U. (2020) · Endocrinology · doi:10.1210/endocr/bqaa001 · Cited by 168
Immunity to CRISPR Cas9 and Cas12a therapeutics
Chew, W. L. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1408 · Cited by 147
Human Germline and Heritable Genome Editing: The Global Policy Landscape
Baylis, F., Darnovsky, M., Hasson, K., & Krahn, T. M. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0082 · Cited by 155
CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
Memi, F., Ntokou, A., & Papangeli, I. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.003 · Cited by 154
Global citizen deliberation on genome editing
Dryzek, J. S., Nicol, D., Niemeyer, S., Pemberton, S., Curato, N., Bächtiger, A., Batterham, P., Bedsted, B., Burall, S., Burgess, M., et al. (2020) · Science · doi:10.1126/science.abb5931 · Cited by 134
Mitochondrial dysfunction and ovarian aging
Wang, T., Zhang, M., Jiang, Z., & Seli, E. U. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12651 · Cited by 116
Critchley, C. R., Nicol, D., Bruce, G., Walshe, J., Treleaven, T., & Tuch, B. E. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00704 · Cited by 111
Beyond safety: mapping the ethical debate on heritable genome editing interventions
Almeida, M., & Ranisch, R. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01147-y · Cited by 103
Sport and exercise genomics: the FIMS 2019 consensus statement update
Tanisawa, K., Wang, G., Seto, J. T., Verdouka, I., Twycross-Lewis, R., Karanikolou, A., Tanaka, M., Börjesson, M., Luigi, L. D., Dohi, M., et al. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2019-101532 · Cited by 96
De Wert, G., Heindryckx, B., Pennings, G., Clarke, A., Eichenlaub-Ritter, U., van El, C. G., Forzano, F., Goddijn, M., Howard, H. C., Radojkovic, D., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-017-0077-z · Cited by 68
Ginoza, M., & Isasi, R. M. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036681 · Cited by 82
Self-citationvan Beers, B. C. (2020) · Journal of Law and the Biosciences · doi:10.1093/jlb/lsaa006 · Cited by 76
The Clinical Application of Gene Editing: Ethical and Social Issues
Ormond, K. E., Bombard, Y., Bonham, V. L., Hoffman‐Andrews, L., Howard, H. C., Isasi, R. M., Musunuru, K., Riggan, K. A., Michie, M., & Allyse, M. A. (2019) · Personalized Medicine · doi:10.2217/pme-2018-0155 · Cited by 59
Self-citationImproving oocyte quality by transfer of autologous mitochondria from fully grown oocytes
Kristensen, S. G., Pors, S. E., & Andersen, C. Y. (2017) · Human Reproduction · doi:10.1093/humrep/dex043 · Cited by 57
Jiao, Z., & Bükülmez, O. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02246-6 · Cited by 53
The ethics of clinical applications of germline genome modification: a systematic review of reasons
van Dijke, I., Bosch, L., Bredenoord, A. L., Cornel, M. C., Repping, S., & Hendriks, S. (2018) · Human Reproduction · doi:10.1093/humrep/dey257 · Cited by 53
The Human Right to Science and the Regulation of Human Germline Engineering
Boggio, A., Knoppers, B. M., Almqvist, J., & Romano, C. P. R. (2019) · The CRISPR Journal · doi:10.1089/crispr.2018.0053 · Cited by 49
Self-citationGermline gene editing and the precautionary principle
Koplin, J. J., Gyngell, C., & Savulescu, J. (2019) · Bioethics · doi:10.1111/bioe.12609 · Cited by 49
Ranisch, R. (2020) · Bioethics · doi:10.1111/bioe.12635 · Cited by 48
Maternal spindle transfer overcomes embryo developmental arrest caused by ooplasmic defects in mice
Costa-Borges, N., Späth, K., Miguel-Escalada, I., Mestres, E., Balmaseda, R., Serafín, A., García-Jiménez, M. G., Vanrell, I., González, J. E., Rink, K., et al. (2020) · eLife · doi:10.7554/elife.48591 · Cited by 48
The ‘serious’ factor in germline modification
Kleiderman, E., Ravitsky, V., & Knoppers, B. M. (2019) · Journal of Medical Ethics · doi:10.1136/medethics-2019-105436 · Cited by 47
Self-citationSchleidgen, S., Dederer, H.-G., Sgodda, S., Cravcisin, S., Lüneburg, L., Cantz, T., & Heinemann, T. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00487-1 · Cited by 43
Global Governance of Human Genome Editing: What Are the Rules?
Marchant, G. E. (2021) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-111320-091930 · Cited by 42
Beyond regulatory compression: confronting the liminal spaces of health research regulation
Taylor‐Alexander, S., Dove, E. S., Fletcher, I., Ganguli‐Mitra, A., McMillan, C. A. W., & Laurie, G. T. (2016) · Law Innovation and Technology · doi:10.1080/17579961.2016.1250378 · Cited by 34
Genome editing: the dynamics of continuity, convergence, and change in the engineering of life
Martin, P. A., Morrison, M. C., Turkmendag, I., Nerlich, B., McMahon, A. M., de Saille, S., & Bartlett, A. (2020) · New Genetics and Society · doi:10.1080/14636778.2020.1730166 · Cited by 34
Legal Issues Regarding Gene Editing at the Beginning of Life: An EU Perspective
Beriaín, Í. D. M. (2017) · Regenerative Medicine · doi:10.2217/rme-2017-0033 · Cited by 31
What do we do now?: Responding to claims of germline gene editing in humans
Allyse, M. A., Bombard, Y., Isasi, R. M., Michie, M., Musunuru, K., & Ormond, K. E. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0492-3 · Cited by 31
Self-citationDisease Resistance and the Definition of Genetic Enhancement
So, D. F., Kleiderman, E., Touré, S. B., & Joly, Y. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00040 · Cited by 29
Self-citationHeritable Genome Editing: Who Speaks for “Future” Children?
Knoppers, B. M., & Kleiderman, E. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0019 · Cited by 28
Self-citationHammerstein, A. L. V., Eggel, M., & Biller‐Andorno, N. (2019) · BMC Medical Ethics · doi:10.1186/s12910-019-0411-9 · Cited by 27
Human gene editing: revisiting Canadian policy
Knoppers, B. M., Isasi, R. M., Caulfield, T., Kleiderman, E., Bedford, P., Illes, J., Ogbogu, U., Ravitsky, V., & Rudnicki, M. A. (2017) · npj Regenerative Medicine · doi:10.1038/s41536-017-0007-2 · Cited by 27
Self-citationThe Regulation of Human Germline Genome Modification in Canada
Kleiderman, E. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108759083.004 · Cited by 26
Self-citationFinding an ethical path forward for mitochondrial replacement
Claiborne, A. B., English, R. A., & Kahn, J. P. (2016) · Science · doi:10.1126/science.aaf3091 · Cited by 26
Ramos, P. D., Almeida, M. S., & Olsson, I. A. S. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1284547 · Cited by 24
Ethical issues in human germline gene editing: a perspective from China
Zhang, D., & Lie, R. K. (2018) · Bioethics News · doi:10.1007/s40592-018-0091-0 · Cited by 22
CRISPR/Cas gene editing in the human germline
Bekaert, B., Boel, A., Cosemans, G., Witte, L. D., Menten, B., & Heindryckx, B. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.012 · Cited by 21
“CRISPR babies”: What does this mean for science and Canada?
Knoppers, B. M., & Kleiderman, E. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.181657 · Cited by 20
Self-citationTherapeutic Application of Genome Editing Technologies in Viral Diseases
Kim, T. H., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105399 · Cited by 20
de Wert, G. M. W. R., Heindryckx, B., Pennings, G., Clarke, A. J., Eichenlaub-Ritter, U., van El, C. G., Forzano, F., Goddijn, M., Howard, H. C., Radojkovic, D. P., et al. (2018) · Human Reproduction Open · doi:10.1093/hropen/hox024 · Cited by 19
The Dilemma of Human Brain Surrogates: Scientific Opportunities, Ethical Concerns
Greely, H. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-38840-9_18 · Cited by 18
Rahimi, A., Sameei, P., Mousavi, S., Ghaderi, K., Hassani, A., Hassani, S., & Alipour, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04143-2 · Cited by 18
Governance of Heritable Human Gene Editing World-Wide and Beyond
Xue, Y., & Shang, L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116739 · Cited by 17
Responsible Translational Pathways for Germline Gene Editing?
Cwik, B. (2020) · Current Stem Cell Reports · doi:10.1007/s40778-020-00179-x · Cited by 17
Goekoop, F., van El, C. G., Widdershoven, G. A. M., Džinalija, N., Cornel, M. C., & Evans, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228263 · Cited by 16
Illes, J., Sipp, D., Kleiderman, E., Benjaminy, S., Isasi, R. M., Lomax, G., Master, Z., McCormick, J. B., Ogbogu, U., Ravitsky, V., et al. (2017) · npj Regenerative Medicine · doi:10.1038/s41536-017-0026-z · Cited by 15
Self-citationDesigning Preclinical Studies in Germline Gene Editing: Scientific and Ethical Aspects
Nordgren, A. (2019) · Journal of Bioethical Inquiry · doi:10.1007/s11673-019-09947-9 · Cited by 15
Genome Editing Technologies as Cellular Defense Against Viral Pathogens
Zhang, Y., & Li, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716344 · Cited by 15
Un análisis ético de las nuevas tecnologías de edición genética: el CRISPR-Cas9 a debate
Beriaín, Í. D. M., & Armaza, E. A. (2017) · Anales de la Cátedra Francisco Suárez · doi:10.30827/acfs.v52i0.6555 · Cited by 14
Cell Lines: Applications and Biosafety
Stacey, G., & Hawkins, J. R. (2016) · ASM Press eBooks · doi:10.1128/9781555819637.ch14 · Cited by 13
The illusion of control in germline-engineering policy
König, H. (2017) · Nature Biotechnology · doi:10.1038/nbt.3884 · Cited by 13
Kleiderman, E., & Stedman, I. (2019) · Journal of Community Genetics · doi:10.1007/s12687-019-00430-x · Cited by 13
Self-citationNicol, D., & Nielsen, J. L. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108620024.018 · Cited by 12
Mitochondrial Replacement Therapy: The Road to the Clinic in Canada
Knoppers, B. M., Leader, A., Hume, S. L., Shoubridge, E. A., Isasi, R. M., Noohi, F., Ogbogu, U., Ravitsky, V., & Kleiderman, E. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.05.007 · Cited by 12
Self-citationDrawing the Line: Disability, Genetic Intervention and Bioethics
Conti, A. (2017) · Laws · doi:10.3390/laws6030009 · Cited by 12
CRISPR technology in human diseases
Feng, Q., Li, Q., Zhou, H., Wang, Z., Lin, C., Jiang, Z., Liu, T., & Wang, D. (2024) · MedComm · doi:10.1002/mco2.672 · Cited by 11
Chapter 12 Gene Editing in Human Embryos. A Comment on the Ethical Issues Involved
Beriaín, Í. D. M., & del Cano, A. M. M. (2018) · Philosophy and medicine · doi:10.1007/978-3-319-60684-2_12 · Cited by 11
Using Genetics for Enhancement (Liberal Eugenics)
Pavlović, S., Ugrin, M., Mićić, S., Gašić, V., Dimitrijević, J., & Barteczko, U. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813764-2.00015-5 · Cited by 8
Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs
Ma, S., Lv, J., Feng, Z., Rong, Z., & Lin, Y. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3377 · Cited by 8
Using CRISPR-Cas9-based genome engineering tools in Drosophila melanogaster
Trivedi, D. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.006 · Cited by 7
A decade of public engagement regarding human germline gene editing: a systematic scoping review
Geuverink, W. P., Houtman, D., Helmrich, I. R., Kist, J. D., Henneman, L., Cornel, M. C., & Riedijk, S. R. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01740-6 · Cited by 7
Правовая среда проведения геномных исследований и перспективы её оптимизации в России
Блинов, А. Г. (2018) · Вестник Омского университета. Серия «Право» · doi:10.25513/1990-5173.2018.4.138-144 · Cited by 7
How bans on germline editing deprive patients with mitochondrial disease
Cohen, I. G., Adashi, E. Y., & Ravitsky, V. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0145-8 · Cited by 7
Gene editing and gender-specific medicine: a challenge for dementia research
Zullo, S., & Caenazzo, L. (2020) · Humanities and Social Sciences Communications · doi:10.1057/s41599-020-0416-5 · Cited by 7
Deciphering the Fragmentation of the Human Genome Editing Regulatory Landscape
Mahalatchimy, A., & Rial‐Sebbag, E. (2022) · Frontiers in Political Science · doi:10.3389/fpos.2021.793134 · Cited by 6
CRISPR Gene Editing Should Be Allowed in Canada, But Under What Circumstances?
Master, Z., & Bedford, P. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.08.028 · Cited by 6
“CRISPR for Disabilities: How to Self-Regulate” or Something?
Courtright-Lim, A. (2022) · Journal of Bioethical Inquiry · doi:10.1007/s11673-021-10162-8 · Cited by 6
Ramos, P. D., Almeida, M. S., & Olsson, I. A. S. (2023) · New Genetics and Society · doi:10.1080/14636778.2023.2237177 · Cited by 6
Contemporary Debates in Bioethics: European Perspectives
Mihailov, E., Wangmo, T., Federiuc, V. V., & Elger, B. S. (2018) · doi:10.2478/9783110571219 · Cited by 6
Human Dignity and Gene Editing: Additional Support for Raposo’s Arguments
Beriaín, Í. D. M., & Sanz, B. (2020) · Journal of Bioethical Inquiry · doi:10.1007/s11673-020-09969-8 · Cited by 6
Editorial: Regulation and governance of gene editing technologies (CRISPR, etc.)
Asquer, A., & Morrison, M. C. (2022) · Frontiers in Political Science · doi:10.3389/fpos.2022.1027410 · Cited by 6
Imperfect Methods for Imperfect Democracies: Increasing Public Participation in Gene Editing Debates
Gregg, B. (2023) · The American Journal of Bioethics · doi:10.1080/15265161.2023.2207506 · Cited by 6
Gazina, N. I., Teymurov, Е. S., & Захарова, Л. И. (2022) · Kutafin Law Review · doi:10.17803/2313-5395.2022.1.19.039-072 · Cited by 5
The Regulation of Human Germline Genome Modification in Spain
Beriaín, Í. D. M., & Casabona, C. M. R. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108759083.014 · Cited by 5
Budgets versus Bans: How U.S. Law Restricts Germline Gene Editing
Johnston, J. (2020) · The Hastings Center Report · doi:10.1002/hast.1094 · Cited by 5
The Regulation of Human Germline Genome Modification in the People’s Republic of China
Song, L., & Isasi, R. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108759083.018 · Cited by 5
Self-citationCRISPR-Cas9 in Functional Genomics: Implications for Target Validation in Precision Oncology
–Hussien, I. F. A., Alkhalidi, M. H. O., Al-Musawi, S., Al-Shalah, L. A. M., & Sheykhhasan, M. (2025) · Trends in Pharmaceutical Biotechnology · doi:10.57238/tpb.2025.153196.1026 · Cited by 4
A society-wide conversation is needed about germline genome editing using CRISPR
Birney, E. (2024) · Nature Medicine · doi:10.1038/s41591-023-02681-1 · Cited by 4
Викторович, Ф. Ф. (2020) · Вестник Российского университета дружбы народов. Серия: Юридические науки · doi:10.22363/2313-2337-2020-24-4-881-900 · Cited by 4
Recent advances in gene therapy for neurological disorders: A comprehensive overview
Jindal, D. (2025) · Adesh University Journal of Medical Sciences & Research · doi:10.25259/aujmsr_20_2025 · Cited by 3
Policy landscapes on human genome editing: a perspective from Latin America
Saldaña‐Tejeda, A., Aparicio, A., González‐Santos, S. P., Ramírez, G. A., Cavalcanti, J. M., Shaw, M. K., & Perler, L. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.07.018 · Cited by 3
Self-Regulation of genetic studies in Russia: search for the optimal model
Alimov, E., & Артемович, Л. Ф. (2021) · Вестник Российского университета дружбы народов. Серия: Юридические науки · doi:10.22363/2313-2337-2021-25-1-126-143 · Cited by 2
Using genetics for enhancement (liberal eugenics)
Pavlović, S., Ugrin, M., Gašić, V., & Rakić, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19045-2.00008-8 · Cited by 2
Zarzeczny, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_450 · Cited by 2
Boggio, A., Romano, C. P. R., & Almqvist, J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108759083.002 · Cited by 2
Edição de genoma com nuclease "Zinc Finger".
de Vasconcelos, M. J. V., & Figueiredo, J. E. F. (2016) · infoteca-e (Brazilian Agricultural Research Corporation) · Cited by 2
Innovation and Interdependence: Evidence from Gene-Editing Technology
O’Brien-Udry, C., & Pratt, T. (2025) · International Studies Quarterly · doi:10.1093/isq/sqaf032 · Cited by 1
1 Good Parents and New Reproductive Technologies
Gyngell, C. (2018) · doi:10.2478/9783110571219-002 · Cited by 1
Суранова, Т. Г., Zenin, S., & Suvorov, G. N. (2020) · Issues of Law · doi:10.14529/pro-prava200312 · Cited by 1
Dove, E. S., & Sethi, N. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108620024.013 · Cited by 1
Domestic and International Regulation of CRISPR
Nestor, M. W., & Wilson, R. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98368-0_8 · Cited by 1
El debate ético y de regulación sobre el uso de CRISPR-Cas9 en la línea germinal humana
Amado, E. D., & Angulo, A. M. G. (2021) · Universitas Médica · doi:10.11144/javeriana.umed62-4.derc · Cited by 1
Genómica y eugenesia: nuevos imaginarios reproductivos y viejos racismos de estado
Saldaña‐Tejeda, A. (2022) · Estudios Sociológicos de El Colegio de México · doi:10.24201/es.2022v40.2081 · Cited by 1
Gazina, N. I. (2024) · Actual Problems of Russian Law · doi:10.17803/1994-1471.2024.163.6.177-189 · Cited by 1
Harrel, N. (2021) · uO Research (University of Ottawa) · doi:10.20381/ruor-26088 · Cited by 1
THOMPSON, R. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.61187 · Cited by 1
LEGAL REGULATION OF BIOETHICAL ISSUES IN THE LIGHT OF MEDICAL SCIENCE ACHIEVEMENTS
Ахтирська, Н. М., & Kostiuchenko, O. Y. (2020) · Wiadomości Lekarskie · doi:10.36740/wlek202012217
Human Gene Editing: Traversing Normative Systems
Isasi, R. M. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108620024.042
Self-citation
Metadata
- Authors
- Isasi, R., Kleiderman, E., & Knoppers, B. M.
- Affiliations
- University of Miami (US)
- McGill University (CA)
- Corresponding author
- Isasi, R.
- Venue
- Science
- Published
- 2016-01-22
- Volume
- 351
- Issue
- 6271
- Pages
- 337-339
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2273649647
- Cited by
- 101
- References
- 11
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 13 · 2021: 12 · 2020: 18 · 2019: 21 · 2018: 7 · 2017: 13 · 2016: 3
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- EUCelLEX EU-FP7 Program (601806)
- Canada Research Chair
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
- Keywords
- genome editing, bioethics, policy thresholds, acceptability, human genome modification, germline editing
- MeSH terms
- Embryo, Mammalian, Germ Cells, Humans, Reproductive Techniques, Genetic Therapy, Genome, Human, Practice Guidelines as Topic, Policy, Stem Cell Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.